Evidence map›Paper›PMID 27756324›Full record

ArticleLipids in health and disease2016

Acid sphingomyelinase as target of Lycium Chinense: promising new action for cell health.

Maria Rachele Ceccarini, Michela Codini, Samuela Cataldi, Samuele Vannini, Andrea Lazzarini, Alessandro Floridi, Massimo Moretti, Milena Villarini, Bernard Fioretti, Tommaso Beccari and 1 more

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Effects of wolfberry (Frontiers in nutrition · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effect of Goji Berry (Animals : an open access journal from MDPI · 2021
    Article
  9. Review
  10. Effect of 1α,25(OH)Cancers · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maria Rachele CeccariniDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Michela CodiniDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Samuela CataldiDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Samuele VanniniDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Andrea LazzariniLaboratory of Nuclear Lipid BioPathology, CRABiON, Perugia, Italy.
Alessandro FloridiLaboratory of Nuclear Lipid BioPathology, CRABiON, Perugia, Italy.
Massimo MorettiDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Milena VillariniDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Bernard FiorettiDepartment of Chemistry, Biology and Biotechnology, University of Perugia, Via Elce di Sotto 8, 06123, Perugia, Italy.
Tommaso BeccariDepartment of Pharmaceutical Science, University of Perugia, Via Fabretti 48, 06122, Perugia, Italy.
Elisabetta AlbiLaboratory of Nuclear Lipid BioPathology, CRABiON, Perugia, Italy. elisabetta.albi@gmail.com.
University of Perugia · ITCrabion (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSphingomyelin plays very important roles in cell function under physiological and pathological conditions. Physical and chemical stimuli produce reactive oxygen species that stimulate acid sphingomyelinase to induce apoptosis. Antioxidant plants of the traditional Chinese Pharmacopoeia, such as Lycium Barbarum and Lycium Chinense, have become increasingly popular in Western countries. We investigated the effects of Lycium Chinense on acid sphingomyelinase and sphingomyelin species in relation to gene expression.

methodsWe prepared Lycium Chinense berry extracts and evaluated their antioxidant properties. Increasing amount of extracts was used to test cytotoxic and genotoxic effect on HepG2 cells. Gene expression, protein amount and enzyme activity of acid sphingomyelinase were tested by RT-PCR, immunoblotting and enzymatic activity assay, respectively. Sphingomyelin species were analyzed by UFLC MS/MS. A panel of 96 genes involved in oxidative stress, proliferation, apoptosis and cancer was used to test the effect of LC on gene expression. GLRX2, RNF7, and PTGS1 proteins were analyzed by immunoblotting.

resultsWe showed that Lycium Chinense berries have high antioxidant properties, have an IC50value of 9.55 mg/mL, do not induce genotoxic effect and maintain high level of cell viability. The berry extracts inhibit acid sphingomyelinase activity and increase both very long fatty acid sphingomyelin species and unsaturated fatty acid sphingomyelin species. Among 96 genes, Lycium Chinense berries up-regulate Glutaredoxin 2 and Ring Finger Protein 7 genes and proteins, able to protect cells from apoptosis. Intrigantly, Lycium Chinense berries down-regulates Prostaglandin H synthase 1 gene but the protein is not expressed in HepG2 cells.

conclusionThe results identify acid sphingomyelinase as a novel target of Lycium Chinense berries to decrease saturated/unsaturated fatty acid sphingomyelin ratio, known to be useful for cell health. Consistent with these data, the berries regulate specifically gene expression to protect cells from apoptosis.

Indexed as

AntioxidantsCell SurvivalFruitGene Expression RegulationHep G2 CellsHumansLyciumMedicine, Chinese TraditionalPlant ExtractsSphingomyelin PhosphodiesteraseSphingomyelinsacid sphingomyelinase-1AntioxidantsPlant ExtractsSphingomyelin PhosphodiesteraseSphingomyelinsAntioxidantFatty acidsLycium chinenseSphingomyelinSphingomyelinase

Identifiers

PMID27756324
PMCPMC5070216
OpenAlexW2534816359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.